Aurinia Pharmaceuticals Inc. logo

Aurinia Pharmaceuticals Inc.

AUPH | NASDAQ
Chart Builder DCF Calculator
$16.73
+$0.12 (+0.72%)
Sep 22, 2026, 1:20 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
287.2M 5.75M -78.02M -108.18M -180.97M -102.68M
Depreciation & Amortization
9.27M 19.45M 11.65M 2.71M 2.76M 1.37M
Stock-Based Compensation
14.68M 31.6M 45.31M 32.3M 31.24M 17.45M
Other Working Capital
4.46M 16.57M 19.63M 1.12M -4.65M 18.45M
Other Non-Cash Items
9.49M -17.85M -6.79M 462K 10.9M 9.48M
Deferred Income Tax
-176.19M n/a n/a n/a n/a n/a
Change in Working Capital
-8.78M 5.45M -5.61M -6.82M -21.63M 4.52M
Operating Cash Flow
135.66M 44.39M -33.46M -79.53M -157.69M -69.86M
Capital Expenditures
-252K -281K -718K -292K -1.5M -7.34M
Cash Acquisitions
n/a n/a n/a n/a -1.2M 1.76M
Purchase of Investments
-526.65M -545.83M -523.5M -523.99M -438.96M -202.95M
Sales Maturities Of Investments
494.13M 585.42M 529.38M 464.32M 354.43M 52.11M
Other Investing Acitivies
n/a -43K -11.86M -663K -16.63M -1.76M
Investing Cash Flow
-32.77M 39.26M -6.71M -60.63M -103.87M -158.19M
Debt Repayment
-13.14M -11.99M -10.03M n/a n/a n/a
Common Stock Repurchased
-98.16M -40.24M n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-9.76M 3.14M 4.9M 2.43M 24.37M 6.64M
Financial Cash Flow
-106.11M -49.09M -5.13M 2.43M 221.11M 194.38M
Net Cash Flow
-3.22M 34.56M -45.3M -137.73M -40.45M -33.67M
Free Cash Flow
135.41M 44.11M -34.18M -79.82M -159.19M -77.2M
Adj. Free Cash Flow
120.73M 12.51M -79.49M -112.12M -190.44M -94.66M
Maintenance CapEx
n/a n/a n/a n/a -1.5M n/a
Growth CapEx
-252K -281K -718K -292K n/a -7.34M
Owner Earnings
135.66M 44.39M -33.46M -79.53M -159.19M -69.86M

© 2026 bestshares.com. All rights reserved.